Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1315

1.

Production of lentiviral vectors for transducing cells from the central nervous system.

Li M, Husic N, Lin Y, Snider BJ.

J Vis Exp. 2012 May 24;(63):e4031. doi: 10.3791/4031.

2.

Packaging HIV- or FIV-based lentivector expression constructs and transduction of VSV-G pseudotyped viral particles.

Mendenhall A, Lesnik J, Mukherjee C, Antes T, Sengupta R.

J Vis Exp. 2012 Apr 8;(62):e3171. doi: 10.3791/3171.

3.

Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.

Pandya S, Boris-Lawrie K, Leung NJ, Akkina R, Planelles V.

Hum Gene Ther. 2001 May 1;12(7):847-57.

PMID:
11339901
4.

Self-inactivating lentiviral vectors with U3 and U5 modifications.

Iwakuma T, Cui Y, Chang LJ.

Virology. 1999 Aug 15;261(1):120-32.

5.

A new-generation stable inducible packaging cell line for lentiviral vectors.

Farson D, Witt R, McGuinness R, Dull T, Kelly M, Song J, Radeke R, Bukovsky A, Consiglio A, Naldini L.

Hum Gene Ther. 2001 May 20;12(8):981-97.

PMID:
11387062
6.

A third-generation lentivirus vector with a conditional packaging system.

Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L.

J Virol. 1998 Nov;72(11):8463-71.

7.

High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.

Mochizuki H, Schwartz JP, Tanaka K, Brady RO, Reiser J.

J Virol. 1998 Nov;72(11):8873-83.

8.

Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.

Ni Y, Sun S, Oparaocha I, Humeau L, Davis B, Cohen R, Binder G, Chang YN, Slepushkin V, Dropulic B.

J Gene Med. 2005 Jun;7(6):818-34. Erratum in: J Gene Med. 2005 Jun;7(6):835.

PMID:
15693055
9.

Mapping of the bovine immunodeficiency virus packaging signal and RRE and incorporation into a minimal gene transfer vector.

Molina RP, Matukonis M, Paszkiet B, Zhang J, Kaleko M, Luo T.

Virology. 2002 Dec 5;304(1):10-23.

10.

Helper plasmids for production of HIV-1-derived vectors.

Fuller M, Anson DS.

Hum Gene Ther. 2001 Nov 20;12(17):2081-93.

PMID:
11747598
11.

The HIV-1 Rev protein enhances encapsidation of unspliced and spliced, RRE-containing lentiviral vector RNA.

Grewe B, Ehrhardt K, Hoffmann B, Blissenbach M, Brandt S, Uberla K.

PLoS One. 2012;7(11):e48688. doi: 10.1371/journal.pone.0048688. Epub 2012 Nov 1.

12.

Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation.

D'Costa J, Brown H, Kundra P, Davis-Warren A, Arya S.

J Gen Virol. 2001 Feb;82(Pt 2):425-34.

PMID:
11161282
13.

Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.

Chang LJ, Urlacher V, Iwakuma T, Cui Y, Zucali J.

Gene Ther. 1999 May;6(5):715-28.

16.

RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.

Bell AJ Jr, Fegen D, Ward M, Bank A.

Exp Biol Med (Maywood). 2010 Oct;235(10):1269-76. doi: 10.1258/ebm.2010.010053. Epub 2010 Sep 27.

PMID:
20876083
18.

Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells.

Mangeot PE, Nègre D, Dubois B, Winter AJ, Leissner P, Mehtali M, Kaiserlian D, Cosset FL, Darlix JL.

J Virol. 2000 Sep;74(18):8307-15.

19.

Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction.

Mitta B, Rimann M, Ehrengruber MU, Ehrbar M, Djonov V, Kelm J, Fussenegger M.

Nucleic Acids Res. 2002 Nov 1;30(21):e113.

20.

Supplemental Content

Support Center